Boosting Tadalafil Bioavailability via Sono-Assisted Nano-Emulsion-Based Oral Jellies: Box–Behnken Optimization and Assessment

Tadalafil (TAD) is a poorly soluble, phosphodiesterase inhibitor used to treat erectile dysfunction. The primary goal of this project was to prepare nano-emulsions using ultrasonic technology to address TAD bioavailability concerns. The Box–Behnken design was employed to find prominent correlations...

詳細記述

書誌詳細

出版年:	Pharmaceutics
主要な著者:	Hany S. M. Ali, Sameh A. Ahmed, Abdulmalik A. Alqurshi, Ali M. Alalawi, Ahmed M. Shehata, Yaser M. Alahmadi
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-11-01
主題:	tadalafil nano-emulsion ultrasonic processing Box–Behnken design jelly bioavailability
オンライン･アクセス:	https://www.mdpi.com/1999-4923/14/12/2592